Clinical Trial: A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices

U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07044401) titled 'A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices' on June 23.

Brief Summary: The main objective of the study is to assess the relative bioavailability of KAI-9531 subcutaneous (SC) injection in the upper arm and thigh compared to the abdomen.

Study Start Date: June 25

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: KAI-9531

SC Injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Kailera

Published by HT Digital Content Services with permission from Health Daily Digest....